Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
MAIA	MAIA Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.40M	n/a	-942.7%	n/a	-$0.70
CING	Cingulate Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.45M	n/a	-894.8%	n/a	-$4.44
ADTX	Aditxt, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.2K	-$43.10M	n/m	-768.3%	-97.6%	-$1153.83
INDP	Indaptus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.85M	n/a	-661.5%	n/a	-$21.58
ERNA	Ernexa Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$14.08M	n/a	-586.6%	n/a	-$2.24
GOVX	GeoVax Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.49M	-$21.46M	-862.3%	-561.2%	-37.1%	n/a
SHPH	Shuttle Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.72M	n/a	-519.9%	n/a	-$7.16
GTBP	GT Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.35M	n/a	-490.0%	n/a	-$6.68
CVKD	Cadrenal Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.24M	n/a	-483.3%	n/a	-$6.64
DARE	Dare Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.03M	-$13.40M	n/m	-471.4%	n/m	-$1.20
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
ATNM	Actinium Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$90.0K	-$33.89M	n/m	-432.6%	n/a	-$1.09
PRPH	ProPhase Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.34M	-$14.74M	-339.3%	-420.3%	-35.8%	-$1.74
LGVN	Longeveron Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.20M	-$22.70M	n/m	-400.1%	-49.9%	-$1.29
LEXX	Lexaria Bioscience Corp. Manufacturing · Year ended 2025-08-31 · USD	$705.9K	-$11.90M	n/m	-398.1%	52.0%	-$0.66
TPST	Tempest Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.26M	n/a	-393.9%	n/a	-$6.33
ALXO	ALX Oncology Holdings Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$101.69M	n/a	-391.4%	n/a	-$1.90
KALA	Kala Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.98M	n/a	-385.6%	n/a	-$3.31
PDSB	PDS Biotechnology Corp Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.50M	n/a	-372.9%	n/a	-$0.74
VSTM	Verastem, Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$209.47M	-677.6%	-366.2%	209.1%	-$3.02
INO	Inovio Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.3K	-$84.95M	n/m	-352.5%	-70.0%	-$1.81
CNSP	CNS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.85M	n/a	-350.5%	n/a	-$35.75
RNAZ	Transcode Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.66M	n/a	-335.4%	n/a	-$52.59
IRD	Opus Genetics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.20M	-$49.59M	-349.3%	-323.1%	29.1%	-$0.80
ENSC	Ensysce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$10.18M	-200.8%	-316.6%	-2.8%	-$3.98

Rows per page: 2550 100